Efficacy of Salmonella typhi Vi capsular polysaccharide vaccine in South Africa [1]

Vaccine

Volumn 15, Issue 17-18, 1997, Pages 1815-

  Wandel, G ^a  

^a Berna Biotech AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TYPHOID VACCINE;

ADOLESCENT; DRUG EFFICACY; HUMAN; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SALMONELLA TYPHI; SALMONELLOSIS; SCHOOL CHILD; SOUTH AFRICA;

EID: 0030735286     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)88855-X     Document Type: Letter

References (5)

1. K.P. Klugman H.J. Koornof J.B. Robbins N.N. Le Cann Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization Vaccine 14 1996 435 438
2. M.M. Levine Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial Lancet 336 1990 891 894
3. M.M. Levine Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation Lancet i 1987 1049 1052
4. Bulletin of the World Health Organization 72 6 1994 957 971 [p. 964; ‘over 60% vaccine efficacy … for at least seven years’]
5. ®